| P2093 | author name string | X Liu | |
| | Z Wu | |
| | H-L Ji | |
| | Y-G Zhang | |
| | J-W Yang | |
| | R-H Tian | |
| P2860 | cites work | Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality | Q24745996 |
| | Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis | Q26852156 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | Meta-analysis in clinical trials | Q27860779 |
| | Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain | Q29615210 |
| | Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem? | Q33803413 |
| | Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry | Q33803499 |
| | Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. | Q33859224 |
| | Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers | Q34357952 |
| | Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. | Q34506457 |
| | The complexities of obesity and diabetes with the development and progression of pancreatic cancer | Q34669361 |
| | Immune-mediated antitumor effect by type 2 diabetes drug, metformin | Q35089957 |
| | Survival of patients with stage IV lung cancer with diabetes treated with metformin | Q35153493 |
| | Meta-analysis, funnel plots and sensitivity analysis | Q35204707 |
| | Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation | Q35290403 |
| | Metformin: multi-faceted protection against cancer | Q35764409 |
| | Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality | Q35817986 |
| | Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer | Q35819793 |
| | Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer | Q36140955 |
| | Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer | Q36303910 |
| | The effect of metformin and thiazolidinedione use on lung cancer in diabetics | Q36453693 |
| | The use of metformin and the incidence of lung cancer in patients with type 2 diabetes | Q36477885 |
| | Metformin and neoplasia: implications and indications | Q37933592 |
| | Metformin does not alter the risk of lung cancer: a case-control analysis. | Q38430462 |
| | Prognosis of small cell lung cancer patients with diabetes treated with metformin | Q40847551 |
| | Metformin use improves the survival of diabetic combined small-cell lung cancer patients | Q40930334 |
| | Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response | Q44362277 |
| | Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan | Q44665632 |
| P433 | issue | 6 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| | meta-analysis | Q815382 |
| | metformin | Q19484 |
| | lung cancer | Q47912 |
| P304 | page(s) | 641-649 | |
| P577 | publication date | 2015-10-12 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis | |
| P478 | volume | 18 | |